Login / Signup
Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma.
Yue Chong
Shan Xu
Tianjie Liu
Peng Guo
Xinyang Wang
Dalin He
Guodong Zhu
Published in:
Current cancer drug targets (2024)
Our finding might indicate that curcumin could inhibit VM by regulating ETS-1, VE-Cadherin, and MMP9 expression in RCC cell lines. Curcumin could be considered as a potential anti-cancer compound by inhibiting VM in RCC progression.
Keyphrases
</>
renal cell carcinoma
transcription factor
poor prognosis
cell migration
signaling pathway
risk assessment
binding protein
long non coding rna